CIK 0000899460 · Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133607736
- Phone
- 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $256,334
- in 2 filings, $256K under 10b5-1 plans
Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | Sabella Lauren M EVP Chief Operating Officer | Grant or award · Performance Restricted Stock Unit | +28,000 | 28,000 | ||
| 2023-05-25 | Grancio Jennifer Director | Grant or award · Restricted Stock Unit | +35,545 | 35,545 | ||
| 2023-05-25 | Thomson David EVP Genl Counsel & Secretary | Grant or award | +92,000 | 827,263 | ||
| 2023-05-25 | Thomson David EVP Genl Counsel & Secretary | Grant or award · Performance Restricted Stock Unit | +113,000 | 113,000 | ||
| 2023-05-25 | CONSIGLIO RONALD J Director | Grant or award · Restricted Stock Unit | +35,545 | 35,545 | ||
| 2023-05-25 | Castagna Michael Chief Executive Officer | Grant or award 10b5-1 | +345,000 | 2,676,735 | ||
| 2023-05-25 | Castagna Michael Chief Executive Officer | Sale 10b5-1 | −75,000 | $4.59 | $344K | 2,601,735 |
| 2023-05-25 | Castagna Michael Chief Executive Officer | Grant or award · Performance Restricted Stock Unit 10b5-1 | +422,000 | 422,000 | ||
| 2023-05-25 | Singh Sanjay R EVP Technical Operations | Grant or award | +68,750 | 287,250 | ||
| 2023-05-25 | Singh Sanjay R EVP Technical Operations | Grant or award · Performance Restricted Stock Unit | +85,000 | 85,000 | ||
| 2023-05-25 | MUNDKUR CHRISTINE Director | Grant or award · Restricted Stock Unit | +35,545 | 35,545 | ||
| 2023-05-25 | Binder Steven B. Chief Financial Officer | Grant or award | +92,000 | 930,324 | ||
| 2023-05-25 | Binder Steven B. Chief Financial Officer | Grant or award · Performance Restricted Stock Unit | +113,000 | 113,000 | ||
| 2023-05-25 | HOOPER ANTHONY C Director | Grant or award · Restricted Stock Unit | +47,393 | 47,393 | ||
| 2023-05-25 | KRESA KENT Director | Grant or award · Restricted Stock Unit | +47,393 | 47,393 | ||
| 2023-05-25 | Friedman Michael A Director | Grant or award · Restricted Stock Unit | +35,545 | 35,545 | ||
| 2023-05-25 | BLANK BURKHARD EVP Chief Medical Officer | Grant or award | +210,000 | 210,000 | ||
| 2023-05-24 | Thomson David EVP Genl Counsel & Secretary | Sale | −95,576 | $4.68 | $448K | 735,263 |
| 2023-05-24 | Binder Steven B. Chief Financial Officer | Sale | −47,810 | $4.68 | $224K | 838,324 |
| 2023-05-24 | Castagna Michael Chief Executive Officer | Sale | −150,000 | $4.69 | $703K | 2,331,735 |
Page 16 of 19 · 361 trades